postmenopausal senile degenerative osteoporosis
Conditions
Interventions
1:alendronate sodium tablets and calcium carbonate D3 chewable tablets
2:alendronate sodium tablets, calcium carbonate D3 chewable tablets and Bushen Tiaochong Recipe
Sponsors
Affiliated Hospital of Qinghai University
Eligibility
Sex/Gender
Female
Age
55 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. In accordance with Guidelines for the diagnosis and treatment of primary osteoporosis (2011); 2. Kidney deficiency and blood stasis syndrome in accordance with Guiding principles of clinical study of new Chinese medicine; 3. Two years of natural menopause; 4. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Metabolic bone disease, such as hyperthyroidism, diabetes, chronic kidney disease; 2. Sex hormone replacement therapy in nearly 3 months; 3. Severe heart, cerebrovascular, liver, kidney, and hematopoietic system diseases; 4. Mental illness; 5. Tumor disease; 6. Bone fracture; 7. Abnormal uterine bleeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale scores for waist and back pain;L2-4 bone mineral density;Serological indicators;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactMeige Qi
Affiliated Hospital of Qinghai University
Outcome results
None listed